MediWound Ltd. Company Profile
NASDAQ: MDWDHealth Care Medicinal Chemicals and Botanical Products USD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
MediWound at a glance
MediWound Ltd. (NASDAQ: MDWD) is a Medicinal Chemicals and Botanical Products company in the Health Care sector headquartered in Yavne, Israel. MediWound is led by Mr. Ofer Gonen B.Sc. and employs about 121 people. The company's shares have traded publicly since 2014.
At a market capitalization of $160.3 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001593984, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does MediWound do?
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
Business description based on the company's public filings.
Company information
- Legal name
- MediWound Ltd.
- Ticker
- NASDAQ: MDWD
- Sector
- Health Care
- Industry
- Medicinal Chemicals and Botanical Products
- CEO
- Mr. Ofer Gonen B.Sc.
- Employees
- 121
- Headquarters
- 42 Hayarkon Street, Yavne, Israel
- Phone
- 972 7 797 14100
- Website
- mediwound.com
- IPO year
- 2014
- Market cap
- $160.35M
- SEC CIK
- 0001593984
Companies similar to MediWound
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| NAGENiagen Bioscience Inc. | 2.66 | -2.21% | $210.48M | vs MDWD |
| USNAUSANA Health Sciences Inc. | 14.66 | -0.07% | $270.87M | vs MDWD |
| RGCRegencell Bioscience Holdings Limited | 7.63 | +7.31% | — | vs MDWD |
| GLASGlass House Brands Inc. Subordinate Voting Shares | 4.41 | -14.04% | $415.61M | vs MDWD |
| TLRYTilray Brands Inc. | 3.59 | -3.36% | $530.54M | vs MDWD |
| TRLVTrulieve Cannabis Corp. Subordinate Voting Shares | 10.37 | -3.80% | $2.00B | vs MDWD |
| DFTXDefinium Therapeutics Inc. | 34.18 | -2.59% | $4.59B | vs MDWD |
| BTIBritish American Tobacco Industries p.l.c. | 55.43 | +2.84% | $119.23B | vs MDWD |